baber/WOPTO huggingface dataset:
Patent ES-2527893-B2 (ES)
Title: Procedimiento para la detección colorimétrica de lisozima por nanopartículas agregadas de oro
Inventor: PRADO GOTOR RAFAEL
IPC: G01N33/493
Filed: 2013-07-30
Granted: 2015-09-18
Abstract: Procedimiento para la detección colorimétrica de lisozima por nanopartículas agregadas de oro. La presente invención tiene por objeto un procedimiento que permite detectar lisozima en disolución acuosa, añadiendo nanopartículas de oro protegidas con iones citrato y agregadas previamente mediante el uso de una sal como es el NaCl a una determinada concentración.#Es una herramienta de diagnóstico médico eficaz que permitirá la detección de diversas patologías como leucemia o enfermedades renales.
Patent ES-2565878-B2 (ES)
Title: Métodos implementados en computador y sistemas informáticos de regulación automática de la cantidad de datos transmitidos entre dispositivos conectados a una red
Inventor: FERNANDEZ MADRIGAL JUAN ANTONIO
IPC: H04L12/801
Filed: 2014-10-31
Granted: 2016-09-09
Abstract: Métodos implementados en computador y sistemas informáticos de regulación automática de la cantidad de datos transmitidos entre dispositivos conectados a una red. La presente invención se refiere a métodos y sistemas que regulan automáticamente la cantidad de datos transmitidos entre dispositivos conectados a una red, ejecutándose para ello diferentes procesos mediante diferentes subsistemas: toma de medidas de tiempo sencillas de un reloj local mediante un subsistema receptor (4) que hace de intermediario entre los nodos consumidor (1) y productor (2), y que a su vez incluye el mantenimiento interno de cierta información; estimación de la probabilidad de cumplir tiempos en las transmisiones, así como el mantenimiento actualizado de dichas estimaciones, mediante un subsistema estimador (5); y toma de decisiones sobre la cantidad de datos a transmitir en cada iteración mediante un subsistema regulador (6) que ejecuta de forma efectiva la función de regulación que satisface los requisitos de tiempo real.
Patent AU-2000277235-B2 (AU)
Title: Improved fire fighting nozzle and method including pressure regulation, chemical and eduction features
Inventor: CRABTREE DENNIS W
IPC: B05B1/32
Filed: 2000-09-27
Granted: 2006-04-27
Abstract: A selectively automatic fire fithting nozzle a method of use including adjustable means (ST) of limiting a range of automatic adjustement (B) of a discharge orifice of the nozzle, providing an option of selecting a constant pressure for a first fraction of a discharge window and selecting a relatively constant flow for a second fraction.
Patent AU-2001288508-B2 (AU)
Title: Method and apparatus for gated ACK/NAK channel in a communication system
Inventor: BENDER PAUL E
IPC: H04L1/18
Filed: 2001-08-28
Granted: 2006-07-06
Abstract: A method and apparatus are disclosed for transmitting ACK/NAK information in a communication system including a transmitter ( 74 ) for transmitting ACK/NAK information on an ACK/NAK channel, and a channel gate ( 699 ) for gating the ACK/NAK channel based on whether a matching preamble is detected in a received data unit by receiver ( 106 ). The data unit is a first data unit in a series of data units comprising a data packet. The channel gate ( 699 ) prevents transmission of the ACK/NAK channel when receiver ( 106 ) has failed to receive the matching preamble in the data unit.
Patent AU-2002235538-B2 (AU)
Title: Method and apparatus for reducing undesired packet generation
Inventor: DEJACO ANDREW P
IPC: G10L19/02
Filed: 2002-02-06
Granted: 2008-02-07
Abstract: A method and apparatus for enhancing coding efficiency by reducing illegal or other undesirable packet generation while encoding a signal, The probability of generating illegal or other undesirable packets while encoding a signal is reduced by first analyzing a history of the frequency of codebook values selected while quantizing speech parameters. Codebook entries are then positioned so that the index/indices that create illegal or other undesirable packets contain the least frequently used entry/entries. Positioning multiple codebooks for various parameters further reduces the probability, that an illegal or other undesirable packet will be created during signal encoding. The method and apparatus may be applied to reduce the probability of generating illegal null traffic channel data packets while encoding eight rate speech.
Patent AU-2002251337-B2 (AU)
Title: The NK1 fragment of hepatocyte growth factors/scatter factor (HGF/SF) and variants thereof, and their use
Inventor: BLUNDELL THOMAS LEON
IPC: C12N5/071
Filed: 2002-04-29
Granted: 2007-08-02
Abstract: The present invention relates to variants of the NK1 fragment of the polypeptide growth factor HGF/SF which act as agonists of the MET receptor and their use. The agonists comprise at least one substitution at positions equivalent to 132, 134, 170 and 181 of full length HGF/SF and these substitutions provide a variant which shows scatter factor activity and induces DNA synthesis. In vivo the variants provide protection from liver damage in a model of acute liver failure.
Patent AU-2002329321-B2 (AU)
Title: Individual plant watering device
Inventor: AMSELLEM MAURICE
IPC: A01G29/00
Filed: 2002-07-01
Granted: 2007-06-28
Abstract: A fitting consisting of a part made of injected plastic for connecting a water tank and a hollow cone made of porous ceramics, so as to produce a device for dispensing water individually to plants, in particular potted plants, proximate to their roots, and in predetermined amount, comprising three coaxial parts; a disc-shape intermediate part with a central hole; a part consisting of one or two cylinders, arranged on one side of the disc and designed to be permanently fixed to the cone; a part consisting of one or two cylinders bearing a thread on the inner surfaces, arranged on the other side of the disc and capable of receiving a bottle removably screwed.
Patent AU-2002353059-B2 (AU)
Title: Processes for the measurement of the potency of glatiramer acetate
Inventor: KLINGER ETY
IPC: G01N33/68
Filed: 2002-12-04
Granted: 2008-06-19
Abstract: The subject invention provides a process for measuring the relative potency of a test batch of glatiramer acetate. In addition, the subject invention provides a process for preparing a batch of glatiramer acetate as acceptable for pharmaceutical use.
Patent AU-2002367975-B2 (AU)
Title: Transition metal complexes with (pyridyl)imidazole ligands
Inventor: HELLER ADAM
IPC: C07F15/00
Filed: 2002-05-10
Granted: 2007-08-16
Abstract: Novel transition metal complexes of iron, cobalt, ruthenium, osmium, and vanadium are described. The transition metal complexes can be used as redox mediators in enzyme-based electrochemical sensors. The transition metal complexes include substituted or unsubstituted(pyridyl)imidazole ligands. Transition metal complexes attached to polymeric backbones are also described.
Patent AU-2003211614-B2 (AU)
Title: Protein or polypeptide having lachrymator synthase activity, DNA encoding the protein or the polypeptide, process for producing protein or polypeptide having lachrymator synthase activity using the DNA, and nucleic acid molecule inhibiting the translation of mRNA concerning the protein or the peptide
Inventor: SHONO JINJI
IPC: C12N15/82
Filed: 2003-02-28
Granted: 2009-02-19
Abstract: A DNA encoding a protein or polypeptide with an effect of converting 1-propenylsulfenic acid into a lachrymator, is new. Independent claims are also included for: (1) a primer for isolating the lachrymator synthase gene of a plant belonging to genus Allium, which contains a sequence of (XXV) comprising 26 base pairs; (2) isolating the Allium lachrymator synthase gene by using the primer; (3) a recombinant vector containing any of the DNAs; (4) a transformant containing the recombinant vector; (5) producing the protein or polypeptide with lachrymator synthase activity; (6) a protein or polypeptide with lachrymator synthase activity containing: (a) an amino acid sequence of (II), (VI), (VIII), (X), (XIV) or (XVI) comprising 164-169 amino acids; (b) an amino acid sequence based on the sequence of (II), (VI), (VIII), (X), (XIV) or (XVI) but with some amino acids added, deleted or substituted; or (c) an amino acid sequence comprising 65 % homology with the sequence of (II), (VI), (VIII), (X), (XIV) or (XVI); and (7) a nucleic acid molecule with a function of inhibiting the translation of mRNA concerning the protein or polypeptide. ACTIVITY : Ophthalmological. No biological data given. MECHANISM OF ACTION : None given.
Patent AU-2003272491-B2 (AU)
Title: Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
Inventor: SIEGEL DONALD L
IPC: C12Q1/68
Filed: 2003-09-18
Granted: 2008-10-02
Abstract: The present invention relates to novel methods for detecting at least one member of a known binding pair in a sample, including a cell, where one member of the pair (termed the "receptor") is expressed by a bacteriophage, which phage is then used to detect the presence of the other member of the pair (termed the "ligand" or "target"). Rather than detecting the binding of at least one phage using antibody-based technology, the present invention relates to detecting the nucleic acid associated with the phages. In one aspect, the invention relates to identifying at least one antigen-bearing moiety (e.g., a red blood cell antigen) of interest present on a cell, e.g., a red blood cell, using antibody-displaying bacteriophages, using antiglobulin reagent-displaying bacteriophages and detecting at least one nucleic acid associated with the phage.
Patent AU-2003279780-B2 (AU)
Title: Hybrid cables with layers which can be used to reinforce tyres
Inventor: BARGUET HENRI
IPC: D07B1/06
Filed: 2003-06-23
Granted: 2009-12-17
Abstract: The invention relates to hybrid cables provided with layers, some of which can be used to reinforce at least one protective crown ply for the wheels of heavy goods vehicles or wheels used in civil engineering vehicles, and others which can be used to reinforce the rims of tyres used in light-duty motor vehicles such as motorcycles. The invention also concerns a composite material which can be used as a protective crown ply for said heavy-goods vehicle or civil engineering vehicle tyres, a bead wire used to reinforce the rims of the tyres, and the above-mentioned tyres. According to the invention, a hybrid cable provided with layers (C) comprises a non-metallic inner layer (Ci) and an outer unsaturated layer (Ce) consisting of strands (T), each of which is at least partially metallic and which are wound in the form of a spiral on said inner layer. The cable has a break elongation At, measured in traction according to standard ISO 6892 (1984), of more than 7 %. According to another aspect of the invention, said inner layer consists of at least one material having a break elongation Ar at 20 DEG C of more than 6 %.
Patent AU-2004202276-B2 (AU)
Title: Novel enzyme
Inventor: SQUIRRELL DAVID JAMES
IPC: G01N21/78
Filed: 2004-05-25
Granted: 2008-05-01
Abstract: A protein having luciferase activity and at least 60% similarity to luciferase from  Photinus pyralis, Luciola mingrelica, Luciola cruciata  or  Luciola lateralis, Hotaria paroula, Pyrophorus plagiophthalamus, Lampyris noctiluca, Pyrocoelia nayako or Photinus pennsylanvanica,  wherein in the sequence of the enzyme, at least one of 
(a) the amino acid residue corresponding to residue 214 in  Photinus pyralis  luciferase; 
(b) the amino acid residue corresponding to residue 232 in  Photinus pyralis  luciferase; 
(c) the amino acid residue corresponding to residue 295 in  Photinus pyralis  luciferase; 
(d) the amino acid residue corresponding to amino acid 14 of the  Photinus pyralis  luciferase; 
(e) the amino acid residue corresponding to amino acid 35 of the  Photinus pyralis  luciferase; 
(f) the amino acid residue corresponding to amino acid residue 105 of the  Photinus pyralis  luciferase; 
(g) the amino acid residue corresponding to amino acid residue 234 of the  Photinus pyralis  luciferase; 
(h) the amino acid residue corresponding to amino acid residue 420 of the  Photinus pyralis  luciferase; 
(i) the amino acid residue corresponding to amino acid residue 310 of the  Photinus pyralis  luciferase;  
is different to the amino acid which appears in the corresponding wild type sequence and wherein the luciferase enzyme has increased thermostability as compared to an enzyme having the amino acid of the corresponding wild-type luciferase at this position.
Patent AU-2004226824-B2 (AU)
Title: Quinoline-2-one-derivatives for the treatment of airways diseases
Inventor: BRUCE IAN
IPC: C07D417/14
Filed: 2004-04-02
Granted: 2008-05-01
Abstract: Compounds of formula I in free or salt form, wherein —C—Y—, R1 and R2 are G have the meanings as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the β2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
Patent AU-2004257935-B2 (AU)
Title: Polypeptide having an improved cytosine deaminase activity
Inventor: ERBS PHILIPPE
IPC: C12N9/78
Filed: 2004-06-29
Granted: 2009-11-19
Abstract: The present invention relates to a polypeptide possessing a CDase activity, characterized in that it is derived from a native CDase by addition of an amino acid sequence with the proviso that said polypeptide has no UPRtase or Thymidine Kinase activity.
Patent AU-2005222994-B2 (AU)
Title: Treatment of fibrosis using FXR ligands
Inventor: PRUZANSKI MARK
IPC: A61K31/56
Filed: 2005-03-14
Granted: 2011-09-01
Abstract: The present invention relates to a method for inhibiting fibrosis that occurs in an organ where the farnesoid X receptor (FXR) is expressed. This method involves the step of administering a high potency, activating ligand of FXR in an effective amount to a patient who is not suffering from a cholestatic condition. The invention also provides pharmaceutical compositions containing an effective amount of an FXR ligand and kits for dispensing the pharmaceutical compositions.
Patent AU-2005254121-B2 (AU)
Title: System and method for monitoring leaks in liquid storage containers
Inventor: SYDNEY MCGEEHAN BRUCE
IPC: G01M3/18
Filed: 2005-06-17
Granted: 2011-08-11
Abstract: A system for monitoring and reporting of leaks in liquid storage container (12) includes a holow tube (26) to partition a volume within the container (12). The partitioned volume is in fluid flow communication with the remainder of the container (12) so that the level of liquid (20) in the partitioned portion corresponds to the level of liquid (22) in the container (12). The system includes a means (16) such as a micro impulse radar device (32) to monitor the depth of the liquid within the tube (14) and means such as compressed air (36) to apply a selected pressure to move the depth of the liquid in the tube to a predetermined level so that monitoring means can bai calibrated. The depth monitoring means (16) also includes a data logger (38), a local display unit (40), a visual or audible alarm system (42) and building data computer system (44).
Patent AU-2005280921-B2 (AU)
Title: Carbamoyl-substituted spiro derivative
Inventor: OHTAKE NORIKAZU
IPC: A61P43/00
Filed: 2005-09-06
Granted: 2011-05-19
Abstract: A compound represented by, e.g. the formula (I):   
[wherein X, Y, Z, and W each independently represent optionally substituted methine; A, B, and D each independently represent -C(O)-, etc.; Q represents a methine or a nitrogen; and R represents the formula (II-1), optionally substituted with lower alkyl, etc.;   
(wherein R 6  represents a lower alkyl, etc; and R 7  and R 8  each independently represents a lower alkyl, etc.)] or a pharmaceutically acceptable salt of the compound. The compounds and salt have antagonistic activity against a histamine H3 receptor or inverse agonistic activity against a histamine H3 receptor. They are useful in the prevention or treatment of metabolic diseases, circulatory diseases, or neurotic diseases.
Patent AU-2006222757-B2 (AU)
Title: Dural graft and method of preparing the same
Inventor: SOMMERICH ROBERT E
IPC: A61L27/24
Filed: 2006-09-28
Granted: 2012-04-12
Abstract: A dural graft is provided having improved stiffness characteristics relative to conventional dural substitutes. The dural graft can be formed from a collagen 5 material having a stiffness between about 0.1 pounds per inch (lb./in.) and 0.25 lb./in. Relative to the collagen material forming conventional dural graft substitutes, the decreased stiffness of the collagen material of the present dural graft can provide the graft with a relatively improved or increased pliability. As a result of the increased pliability, the dural graft can sufficiently conform to a curvature of a tissue surface to 10 which it is applied, such as the curved surface of a meningeal membrane. The reduced stiffness of the collagen material can also provide for a relatively improved or increased flexibility or elasticity of the dural graft. The increased flexibility of the dural graft minimizes tearing of the graft when handled or manipulated during an implantation procedure. 27/09/06,16047 specificaion,2 10 16FIG. 2 isFIG. 3
Patent AU-2006254796-B2 (AU)
Title: Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes
Inventor: WUSTMAN BRANDON
IPC: A01N43/40
Filed: 2006-06-08
Granted: 2012-08-16
Abstract: Described is a method for treating an individual having a neurological disorder with an associated mutation or mutations in a gene encoding a lysosomal enzyme. Specifically, the individual is administered a specific pharmacological chaperone for the lysosomal enzyme which increases trafficking of the protein from the ER to the lysosome in neural cells, with or without concomitantly increasing enzyme activity in neural cells. Restoration of trafficking relieves cell stress and other toxicities associated with accumulation of mutant proteins. Restoration of enzyme activity relieves substrate accumulation and pathologies associated with lipid accumulation. In a specific embodiment, the neurological disorder is Parkinson's disease or parkinsonism which is associated with mutations in glucocerebrosidase.
Patent AU-2006259411-B2 (AU)
Title: Prodrugs of A2B adenosine receptor antagonists
Inventor: ZABLOCKI JEFF
IPC: A61K31/522
Filed: 2006-06-14
Granted: 2012-03-22
Abstract: Disclosed are prodrugs of A adenosine receptor antagonists, and their use in treating mammals for various disease states.
Patent AU-2006310761-B2 (AU)
Title: Call interceptor
Inventor: MCFEETERS KENNETH
IPC: H04M1/663
Filed: 2006-11-01
Granted: 2012-03-08
Abstract: An apparatus for selectively allowing calls to a device, especially a facsimile machine, that may receive calls on a signal line. The apparatus detects an incoming call on the signal line and allows the incoming call to reach the device if received during an enabled time period but prevents the incoming call from reaching the device if received outside the enabled time period. The apparatus may be configured to prevent a first incoming call, detected outside said enabled period, from reaching said device and subsequently to initiate said enabled time period.
Patent AU-2006311829-B2 (AU)
Title: Methods of treating cancers with SAHA, carboplatin, and paclitaxel and other combination therapies
Inventor: PARADISE CAROLYN
IPC: A61K31/16
Filed: 2006-11-03
Granted: 2012-10-11
Abstract: The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof an amount of a histone deacetylase (HDAC) inhibitor, e.g., suberoylanilide hydroxamic acid (SAHA), or a pharmaceutically acceptable salt or hydrate thereof, and an amount of one or more anticancer agents such as Carboplatin or Paclitaxel. The HDAC inhibitor and the anticancer agents may be administered to comprise therapeutically effective amounts.
Patent AU-2006314226-B2 (AU)
Title: Therapeutic uses of steroidal compounds
Inventor: WULFERT ERNST
IPC: A61K31/568
Filed: 2006-11-17
Granted: 2012-02-02
Abstract: A steroid derivative compound of formula (I) in which: one of R and R is hydroxy and the other is hydrogen; or R and R together represent oxo; R is hydrogen or hydroxy; and the dotted lines represent single or double carbon-carbon bonds; and pharmaceutically acceptable salts and esters thereof are useful for the prevention or treatment of pain, for improving nerve regeneration after nerve injury or damage or disease, for the prevention or treatment of brain injury, damage or disease and for neuroprotection. Particularly useful compounds are 11-hydroxy-Δ4-androstene-3,17-dione and 11-oxo-Δ4-androstene-3,17-dione or their derivatives.
Patent AU-2006346692-B2 (AU)
Title: Improvements to capsules containing a substance in powder form from which a beverage, preferably espresso coffee, is to be extracted
Inventor: VAN EEDEN FRANS
IPC: B65D85/804
Filed: 2006-12-04
Granted: 2013-04-04
Abstract: A capsule for extracting a beverage from a substance in powder form, preferably ground coffee, by means of pressurized water, comprising a box- like body (2, 3) which contains the substance in powder form (4) and has a base provided with an output port (8) for the outflow of the extracted beverage, the output port (8) being closed by an elastic crema forming septum (9) which can open under the pressure of the water, the capsule further comprising a safety lid (111) which is mounted on the box-like body at the base so as to increase the axial size of the box-like body, the lid (111) comprising a shoulder (112) which is engaged on the septum (9) and is adapted to retain the septum (9) within the capsule.
Patent AU-2007224888-B2 (AU)
Title: Torque limiter
Inventor: PETER WITTE
IPC: F16D7/10
Filed: 2007-03-14
Granted: 2011-10-06
Abstract: Disclosed is a torque limiter, especially for a surgical screwdriver, comprising an outer sleeve (10) whose inner wall is provided with at least one circumferential groove (12) and a plurality of axially parallel recesses (14), one or several elastic rings (16) that is/are inserted into the groove/s (12), a roller cage (20) which is accommodated by the outer sleeve (10) and is equipped with a number of roller receptacles (18) corresponding to the number of recesses (14), a plurality of rollers (22) that are inserted into the roller receptacles (18), an inner sleeve (24) which is accommodated by the roller cage (20) and whose outer wall is fitted with a number of axially parallel, V-shaped notches (26) corresponding to the number of roller receptacles (18), and means for limiting the relative rotation between the roller cage (20) and the outer sleeve (10) between a first position, which is taken when the outer sleeve (10) is rotated in the twisting direction and in which the means cause torque to be transmitted while the rollers (22) are flush with the recesses (14), leave the notches (26) in the inner sleeve (26), and enter the recesses (14) in the outer sleeve (10) so as to displace the elastic ring/s (16) when the maximum torque that is to be transmitted has been reached, and a second position, which is taken when the outer sleeve (10) is rotated in the releasing direction and in which the rollers (22) accommodated by the notches (26) in the inner sleeve (24) are in a position that is offset relative to the recesses (14) in the outer sleeve (10).